Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Tech Reporter.
Press releases published on May 29, 2025
Incannex Healthcare Inc. Advances IHL-42X RePOSA Trial to Phase 3 Following FDA Protocol Clearance
GlobeNewswire
·
May 29, 2025
NEW YORK and MELBOURNE, Australia, May 29, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage pharmaceutical company developing novel combination therapies, today announced that the Phase 3 component of the RePOSA clinical …
Crescent Biopharma to Present at the Jefferies Global Healthcare Conference
GlobeNewswire
·
May 29, 2025
WALTHAM, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent”), a private biotechnology company developing novel precision-engineered molecules targeting validated biology to advance care for patients with solid tumors, today …
Veson Nautical Expands IMOS Platform with AI-Powered Claims Management
GlobeNewswire
·
May 29, 2025
BOSTON, May 29, 2025 (GLOBE NEWSWIRE) -- Veson Nautical (Veson), a global leader in maritime data and freight management solutions, today announced the launch of IMOS X Claims CoCaptain, an AI-powered extension of claims management capabilities within IMOS …
uniQure Presents Clinical Case Study of First Patient Dosed with AMT-260 in Refractory Mesial Temporal Lobe Epilepsy (MTLE)
GlobeNewswire
·
May 29, 2025
~ No serious adverse events and 92% reduction in seizure frequency observed in the first trial participant through first five months of follow up ~ ~ Data to be presented today at Epilepsy Therapies …
Zenas BioPharma to Present at the Jefferies Global Healthcare Conference
GlobeNewswire
·
May 29, 2025
WALTHAM, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of therapies for …
Syndax Announces Participation in June Investor Conferences
GlobeNewswire
·
May 29, 2025
NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that Michael A. Metzger, Chief Executive Officer of Syndax, as well as …
FactSet Schedules Third Quarter 2025 Earnings Call
GlobeNewswire
·
May 29, 2025
NORWALK, Conn., May 29, 2025 (GLOBE NEWSWIRE) -- FactSet (NYSE: FDS | NASDAQ: FDS), a global financial digital platform and enterprise solutions provider, today announced it will release its financial and operating results for the third quarter fiscal 2025 …
Kymera Therapeutics to Participate in Upcoming June Investor Conferences
GlobeNewswire
·
May 29, 2025
WATERTOWN, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced that the …
Dianthus Therapeutics to Webcast Presentation at the Jefferies Global Healthcare Conference
GlobeNewswire
·
May 29, 2025
NEW YORK and WALTHAM, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune …
Seer Redefining Deep Unbiased Proteomics with Launch of New Proteograph Workflow at ASMS 2025, Enabling Previously Unattainable Scale and Efficiency
GlobeNewswire
·
May 29, 2025
REDWOOD CITY, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced the launch of its new Proteograph® Product Suite, featuring the Proteograph ONE Assay …
Lantronix to Showcase AI-Driven LM4 Out-of-Band Management Console Servers at Cisco Live San Diego
GlobeNewswire
·
May 29, 2025
IRVINE, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Lantronix Inc. (NASDAQ: LTRX), a global leader of compute and connectivity for IoT solutions enabling Edge AI Intelligence, today announced that it will do live demos and daily giveaways of its LM4 AI-driven …
PyroGenesis Achieves Approved Supplier Status with Boeing
GlobeNewswire
·
May 29, 2025
MONTREAL, May 29, 2025 (GLOBE NEWSWIRE) -- PyroGenesis Inc. (http://pyrogenesis.com) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), a high-tech company that designs, develops, manufactures and commercializes advanced all-electric plasma processes and sustainable …
Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2025, and Provides Business Update
GlobeNewswire
·
May 29, 2025
BASEL, Switzerland and LONDON and NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today reported its financial results for the fourth quarter and fiscal year ended March 31, 2025, and provided a business update. Brepocitinib program …
Auron Announces First Patient Dosed in Phase 1 Clinical Trial of AUTX-703 in Advanced Hematologic Malignancies
GlobeNewswire
·
May 29, 2025
NEWTON, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Auron Therapeutics, a clinical-stage biotechnology company targeting cell-state plasticity to improve patient outcomes in oncology and inflammatory disease, today announced that the first patient has been …
PyroGenèse obtient le statut de fournisseur approuvé auprès de Boeing
GlobeNewswire
·
May 29, 2025
MONTRÉAL, 29 mai 2025 (GLOBE NEWSWIRE) -- PyroGenèse Inc. (http://PyroGenesis.com) (TSX : PYR) (OTCQX : PYRGF) (FRA : 8PY1), une entreprise de haute technologie qui conçoit, développe, fabrique et commercialise des procédés plasma entièrement électriques …
Cullinan Therapeutics to Host Analyst and Investor Event at 2025 ASCO Annual Meeting and Participate in Jefferies 2025 Global Healthcare Conference
GlobeNewswire
·
May 29, 2025
CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM; “Cullinan”), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today announced its management team will host a company event …
Xtract One Announces Fiscal 2025 Third Quarter Conference Call
GlobeNewswire
·
May 29, 2025
TORONTO, May 29, 2025 (GLOBE NEWSWIRE) -- Xtract One Technologies Inc. (TSX: XTRA) (OTCQX: XTRAF) (FRA: 0PL) (“Xtract One” or the “Company”), a leading technology-driven threat detection and security solution that prioritizes the patron access experience …
Plug Power’s Georgia Hydrogen Plant Sets U.S. Production Record Using Plug Electrolyzer Technology
GlobeNewswire
·
May 29, 2025
WOODBINE, Ga., May 29, 2025 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions, announced today that its hydrogen plant in Woodbine, Georgia produced 300 metric tons of liquid hydrogen in April 2025—the …
Tilray Brands to Present at TD Cowen’s 9th Annual Future of the Consumer Conference
GlobeNewswire
·
May 29, 2025
NEW YORK and LEAMINGTON, Ontario, May 29, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”) (NASDAQ: TLRY and TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, today …
Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2025
GlobeNewswire
·
May 29, 2025
Immunovant’s new management team is focused on rapid clinical execution for the six announced indications for IMVT-1402, including a second potentially registrational study in Graves’ disease (GD) and a potentially registrational study in Sjögren’s disease …